Efficient Identification of Response to Cytarabine Idarubicin in Newly Diagnosed Acute Myeloid Leukemia by a New Individualized Medicine Test Based on ex vivo Pharmacology
Services
Services
Date issued
2014Journal title
Clinical Lymphoma Myeloma & Leukemia
Type of content
Publicación de congreso
